Cangene (FRA:YGE) ROE % Adjusted to Book Value : -12.08% (As of Oct. 2013)

View and export this data going back to . Start your Free Trial

What is Cangene ROE % Adjusted to Book Value?

Cangene's ROE % for the quarter that ended in Oct. 2013 was -10.51%. Cangene's PB Ratio for the quarter that ended in Oct. 2013 was 0.87. Cangene's ROE % Adjusted to Book Value for the quarter that ended in Oct. 2013 was -12.08%.

Cangene ROE % Adjusted to Book Value Historical Data

The historical data trend for Cangene's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cangene ROE % Adjusted to Book Value Chart

Cangene Annual Data

Trend

Jul04

Jul05

Jul06

Jul07

Jul08

Jul09

Jul10

Jul11

Jul12

Jul13

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-28.63

0.84

Cangene Quarterly Data
	Jan09	Apr09	Jul09	Oct09	Jan10	Apr10	Jul10	Oct10	Jan11	Apr11	Jul11	Oct11	Jan12	Apr12	Jul12	Oct12	Jan13	Apr13	Jul13	Oct13
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-	-	7.65	-9.15	-12.08

Competitive Comparison of Cangene's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Cangene's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cangene's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cangene's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Cangene's ROE % Adjusted to Book Value falls into.

Cangene ROE % Adjusted to Book Value Calculation

Cangene's ROE % Adjusted to Book Value for the fiscal year that ended in Jul. 2013 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.67%	/	0.80
	=	0.84%

Cangene's ROE % Adjusted to Book Value for the quarter that ended in Oct. 2013 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-10.51%	/	0.87
	=	-12.08%

Cangene ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Cangene's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Cangene (FRA:YGE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cangene Corporation (FRA:YGE) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.cangene.com

Cangene Corporation is a fully integrated developer and manufacturer of immune therapeutics, primarily targeting infectious disease, hematology, transplantation and biodefense applications. The company manages its business and evaluate performance based on two operating segments: biopharmaceutical operations and contract services. Revenues are generated from product sales, and contract manufacturing and contract-R&D services.

Cangene (FRA:YGE) Headlines

No Headlines